Encouse Golden

Encouse Golden

Encouse B. Golden, M.D., Ph.D.

Assistant Professor
Department of Radiation Oncology

University of California, San Francisco
505 Parnassus Avenue, Room L-08
San Francisco, CA 94143
Phone: 415 353-3675
Fax: 415 353-8679
Email: Encouse.Golden@ucsf.edu

Make A Gift Button


Professional Focus

Dr. Encouse Golden is a Board Certified Radiation Oncologist who specializes in treating tumors of the central nervous system, including primary brain and spinal tumors and tumors that have metastasized to the brain and spine. He is involved in multiple clinical trials with a focus on treating these types of tumors. He routinely uses various modalities of radiation oncology, including 3D conformal RT, intensity modulated RT (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), Gamma Knife, and CyberKnife.

Dr. Encouse Golden has helped to shape the new and evolving field of radiation and immunotherapy by showing how the use of radiation may contribute to a form of tumor cell death (immunogenic cell death) that can be utilized as a personalized anti-tumor vaccine. In addition, he is the lead author on the first clinical trial showing how local radiotherapy to a tumor in combination with immunotherapy can generate immune-mediated abscopal (from Latin ab-scopus, away from the target) responses in distant, non-irradiated, sites of disease that lead to improved patient survival.


1998-2001 University of Southern California BS Biology
2001-2009 University of Southern California, Keck School of Medicine MD Medicine
2001-2009 University of Southern California, Keck School of Medicine PhD Pathobiology
2009-2010 University of Chicago, Pritzker School of Medicine Intern Neurosurgery
2011-2012 New York University, School of Medicine Postdoctoral Fellow Radiation Biology
2010-2014 New York University, School of Medicine Resident Radiation Oncology

Professional Experience

2014-2015 New York University, School of Medicine Clinical Instructor Radiation Oncology
2014-2015 New York University, Langone Medical Center Attending Physician Radiation Oncology
2015-2017 Cornell University, Weill Cornell Medical College Assistant Professor Radiation Oncology
2015-2017 New York Presbyterian Hospital Attending Physician Radiation Oncology
2017-Present University of California, San Francisco Assistant Professor Radiation Oncology

Awards & Honors

2011 Chemotherapy Foundation: Competitive Research Fellowship Award
2011 Lynn Sage: Breast Cancer Achievement Award
2012 Radiation Research Society (RRS): Scholar in Training Travel Award
2012 NYU School of Medicine Excellence in Laboratory Research during Residency Award
2015 American Society for Radiation Oncology: Basic/Translational Science Abstract Award


Recent Significant Publications :

Daillere R, Vetizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016;45(4):931-43. doi: 10.1016/j.immuni.2016.09.009. PubMed PMID: 27717798.

Halpern JA, Sedrakyan A, Hsu WC, Mao J, Daskivich TJ, Nguyen PL, Golden EB, Kang J, Hu JC. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer. Cancer. 2016;122(16):2496-504. doi: 10.1002/cncr.30101. PubMed PMID: 27224858; PMCID: PMC4974119.

Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, Berard M, Nigou J, Opolon P, Eggermont A, Woerther PL, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079-84. doi: 10.1126/science.aad1329. PubMed PMID: 26541610; PMCID: PMC4721659.

Golden EB, Chhabra A, Chachoua A, Adams S, Donach M, Fenton-Kerimian M, Friedman K, Ponzo F, Babb JS, Goldberg J, Demaria S, Formenti SC. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol. 2015;16(7):795-803. doi: 10.1016/S1470-2045(15)00054-6. PubMed PMID: 26095785.

Golden EB, Shin SM, Schiff PB, Formenti SC. Radiotherapy for extensive stage small-cell lung cancer. Lancet. 2015;385(9975):1290-1. doi: 10.1016/S0140-6736(15)60675-4. PubMed PMID: 25890907.

Wang W, Sivakumar W, Torres S, Jhaveri N, Vaikari VP, Gong A, Howard A, Golden EB, Louie SG, Schonthal AH, Hofman FM, Chen TC. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Neurosurg Focus. 2015;38(3):E8. doi: 10.3171/2015.1.FOCUS14743. PubMed PMID: 25727230.

Golden EB, Cho HY, Hofman FM, Louie SG, Schonthal AH, Chen TC. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg Focus. 2015;38(3):E12. doi: 10.3171/2014.12.FOCUS14748. PubMed PMID: 25727221.

Golden EB, Formenti SC. Radiation therapy and immunotherapy: growing pains. Int J Radiat Oncol Biol Phys. 2015;91(2):252-4. doi: 10.1016/j.ijrobp.2014.09.018. PubMed PMID: 25636751.

Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Schonthal AH, Chen TC. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus. 2014;37(6):E12. doi: 10.3171/2014.9.FOCUS14504. PubMed PMID: 25434381.

Golden EB, Frances D, Pellicciotta I, Demaria S, Helen Barcellos-Hoff M, Formenti SC. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology. 2014;3:e28518. doi: 10.4161/onci.28518. PubMed PMID: 25071979; PMCID: PMC4106151.